FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 ORAL Beverly Hills Rejuvenation Center FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Latest FDA FTC warning letters continue trend of disease ifying structure function claims Council for Responsible Nutrition